Terms: = Breast cancer AND FOXA1, TCF3A, 3169, ENSG00000129514, P55317, HNF3A, MGC33105 AND Diagnosis
17 results:
1. Integrated Bioinformatics Analysis for the Screening of Hub Genes and Therapeutic Drugs in Androgen Receptor-Positive TNBC.
Guo Q; Qiu P; Yao Q; Chen J; Lin J
Dis Markers; 2022; 2022():4964793. PubMed ID: 36157217
[TBL] [Abstract] [Full Text] [Related]
2. Time-varying effects of foxa1 on breast cancer prognosis.
Chen QX; Yang YZ; Liang ZZ; Chen JL; Li YL; Huang ZY; Weng ZJ; Zhang XF; Guan JX; Tang LY; Yun JP; Ren ZF
Breast Cancer Res Treat; 2021 Jun; 187(3):867-875. PubMed ID: 33604715
[TBL] [Abstract] [Full Text] [Related]
3. Revealing clonality and subclonality of driver genes for clinical survival benefits in breast cancer.
Lan Y; Zhao E; Luo S; Xiao Y; Li X; Cheng S
Breast Cancer Res Treat; 2019 May; 175(1):91-104. PubMed ID: 30739230
[TBL] [Abstract] [Full Text] [Related]
4. Regulators of Asymmetric Cell Division in breast cancer.
Ragoussis J
Trends Cancer; 2018 Dec; 4(12):798-801. PubMed ID: 30470301
[TBL] [Abstract] [Full Text] [Related]
5. Effects of forkhead Box protein A1 on cell proliferation regulating and EMT of cervical carcinoma.
Gu F; Li ZH; Wang CQ; Yuan QF; Yan ZM
Eur Rev Med Pharmacol Sci; 2018 Nov; 22(21):7189-7196. PubMed ID: 30468461
[TBL] [Abstract] [Full Text] [Related]
6. Expression and prognosis analyses of forkhead box A (FOXA) family in human lung cancer.
Huang C; Liu J; Xiong B; Yonemura Y; Yang X
Gene; 2019 Feb; 685():202-210. PubMed ID: 30415009
[TBL] [Abstract] [Full Text] [Related]
7. breast cancer metastasis to gynaecological organs: a clinico-pathological and molecular profiling study.
Kutasovic JR; McCart Reed AE; Males R; Sim S; Saunus JM; Dalley A; McEvoy CR; Dedina L; Miller G; Peyton S; Reid L; Lal S; Niland C; Ferguson K; Fellowes AP; Al-Ejeh F; Lakhani SR; Cummings MC; Simpson PT
J Pathol Clin Res; 2019 Jan; 5(1):25-39. PubMed ID: 30246500
[TBL] [Abstract] [Full Text] [Related]
8. Comprehensive clinical and molecular analyses of neuroendocrine carcinomas of the breast.
Lavigne M; Menet E; Tille JC; Lae M; Fuhrmann L; Bonneau C; Deniziaut G; Melaabi S; Ng CCK; Marchiò C; Rouzier R; Bièche I; Vincent-Salomon A
Mod Pathol; 2018 Jan; 31(1):68-82. PubMed ID: 28884749
[TBL] [Abstract] [Full Text] [Related]
9. Suppression of OGT by microRNA24 reduces foxa1 stability and prevents breast cancer cells invasion.
Liu Y; Huang H; Cao Y; Wu Q; Li W; Zhang J
Biochem Biophys Res Commun; 2017 Jun; 487(3):755-762. PubMed ID: 28455227
[TBL] [Abstract] [Full Text] [Related]
10. Lobular breast cancer: Clinical, molecular and morphological characteristics.
Christgen M; Steinemann D; Kühnle E; Länger F; Gluz O; Harbeck N; Kreipe H
Pathol Res Pract; 2016 Jul; 212(7):583-97. PubMed ID: 27233940
[TBL] [Abstract] [Full Text] [Related]
11. A Gene Regulatory Program in Human breast cancer.
Li R; Campos J; Iida J
Genetics; 2015 Dec; 201(4):1341-8. PubMed ID: 26510790
[TBL] [Abstract] [Full Text] [Related]
12. TFAP2C expression in breast cancer: correlation with overall survival beyond 10 years of initial diagnosis.
Perkins SM; Bales C; Vladislav T; Althouse S; Miller KD; Sandusky G; Badve S; Nakshatri H
Breast Cancer Res Treat; 2015 Aug; 152(3):519-31. PubMed ID: 26160249
[TBL] [Abstract] [Full Text] [Related]
13. The transcriptional regulation of SOX2 on foxa1 gene and its application in diagnosis of human breast and lung cancers.
Li X; Chen S; Sun T; Xu Y; Chen Y; Liu Y; Xiang R; Li N
Clin Lab; 2014; 60(6):909-18. PubMed ID: 25016694
[TBL] [Abstract] [Full Text] [Related]
14. foxa1: a promising prognostic marker in breast cancer.
Hu Q; Luo Z; Xu T; Zhang JY; Zhu Y; Chen WX; Zhong SL; Zhao JH; Tang JH
Asian Pac J Cancer Prev; 2014; 15(1):11-6. PubMed ID: 24528009
[TBL] [Abstract] [Full Text] [Related]
15. Gene expression signatures differentiate adenocarcinoma of lung and breast origin in effusions.
Davidson B; Stavnes HT; Risberg B; Nesland JM; Wohlschlaeger J; Yang Y; Shih IeM; Wang TL
Hum Pathol; 2012 May; 43(5):684-94. PubMed ID: 21937081
[TBL] [Abstract] [Full Text] [Related]
16. Gene expression signatures differentiate ovarian/peritoneal serous carcinoma from breast carcinoma in effusions.
Davidson B; Stavnes HT; Holth A; Chen X; Yang Y; Shih IeM; Wang TL
J Cell Mol Med; 2011 Mar; 15(3):535-44. PubMed ID: 20132413
[TBL] [Abstract] [Full Text] [Related]
17. Identification of novel genes that co-cluster with estrogen receptor alpha in breast tumor biopsy specimens, using a large-scale real-time reverse transcription-PCR approach.
Tozlu S; Girault I; Vacher S; Vendrell J; Andrieu C; Spyratos F; Cohen P; Lidereau R; Bieche I
Endocr Relat Cancer; 2006 Dec; 13(4):1109-20. PubMed ID: 17158757
[TBL] [Abstract] [Full Text] [Related]
